Logo image of BILI

BILIBILI INC-SPONSORED ADR (BILI) Stock Fundamental Analysis

NASDAQ:BILI - Nasdaq - US0900401060 - ADR - Currency: USD

22.82  +0.71 (+3.21%)

After market: 22.81 -0.01 (-0.04%)

Fundamental Rating

2

Taking everything into account, BILI scores 2 out of 10 in our fundamental rating. BILI was compared to 71 industry peers in the Interactive Media & Services industry. Both the profitability and financial health of BILI have multiple concerns. BILI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year BILI was profitable.
BILI had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BILI reported negative operating cash flow in multiple years.
BILI Yearly Net Income VS EBIT VS OCF VS FCFBILI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2B -4B -6B

1.2 Ratios

With a Return On Assets value of -12.79%, BILI perfoms like the industry average, outperforming 42.42% of the companies in the same industry.
With a Return On Equity value of -29.48%, BILI perfoms like the industry average, outperforming 42.42% of the companies in the same industry.
Industry RankSector Rank
ROA -12.79%
ROE -29.48%
ROIC N/A
ROA(3y)-15.17%
ROA(5y)-13.29%
ROE(3y)-38%
ROE(5y)-34.38%
ROIC(3y)N/A
ROIC(5y)N/A
BILI Yearly ROA, ROE, ROICBILI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

The Gross Margin of BILI (27.35%) is worse than 81.82% of its industry peers.
BILI's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BILI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.68%
GM growth 5Y3.13%
BILI Yearly Profit, Operating, Gross MarginsBILI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

2

2. Health

2.1 Basic Checks

BILI does not have a ROIC to compare to the WACC, probably because it is not profitable.
BILI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BILI Yearly Shares OutstandingBILI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M
BILI Yearly Total Debt VS Total AssetsBILI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B 50B

2.2 Solvency

BILI has an Altman-Z score of 1.40. This is a bad value and indicates that BILI is not financially healthy and even has some risk of bankruptcy.
BILI has a Altman-Z score (1.40) which is comparable to the rest of the industry.
BILI has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
BILI's Debt to Equity ratio of 0.36 is on the low side compared to the rest of the industry. BILI is outperformed by 62.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 1.4
ROIC/WACCN/A
WACC6.99%
BILI Yearly LT Debt VS Equity VS FCFBILI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 1.02 indicates that BILI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.02, BILI is doing worse than 75.76% of the companies in the same industry.
BILI has a Quick Ratio of 1.02. This is a normal value and indicates that BILI is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.02, BILI is not doing good in the industry: 75.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
BILI Yearly Current Assets VS Current LiabilitesBILI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 130.62% over the past year.
EPS 1Y (TTM)130.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%202.72%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%37.8%

3.2 Future

BILI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 221.17% yearly.
The Revenue is expected to grow by 9.93% on average over the next years. This is quite good.
EPS Next Y9274.08%
EPS Next 2Y1103.97%
EPS Next 3Y484.1%
EPS Next 5Y221.17%
Revenue Next Year13.06%
Revenue Next 2Y11.37%
Revenue Next 3Y12.9%
Revenue Next 5Y9.93%

3.3 Evolution

BILI Yearly Revenue VS EstimatesBILI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B 50B
BILI Yearly EPS VS EstimatesBILI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 -10 20

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

BILI is valuated quite expensively with a Price/Earnings ratio of 78.69.
BILI's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of BILI to the average of the S&P500 Index (29.63), we can say BILI is valued expensively.
The Price/Forward Earnings ratio is 22.63, which indicates a rather expensive current valuation of BILI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BILI is on the same level as its industry peers.
BILI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 78.69
Fwd PE 22.63
BILI Price Earnings VS Forward Price EarningsBILI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BILI Per share dataBILI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BILI's earnings are expected to grow with 484.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y1103.97%
EPS Next 3Y484.1%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BILI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BILIBILI INC-SPONSORED ADR

NASDAQ:BILI (2/21/2025, 8:03:28 PM)

After market: 22.81 -0.01 (-0.04%)

22.82

+0.71 (+3.21%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)02-20 2025-02-20/bmo
Earnings (Next)N/A N/A
Inst Owners18.19%
Inst Owner Change-10.41%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap9.51B
Analysts82.11
Price Target23.13 (1.36%)
Short Float %6.08%
Short Ratio3.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.82%
Min EPS beat(2)13.23%
Max EPS beat(2)14.41%
EPS beat(4)3
Avg EPS beat(4)8.27%
Min EPS beat(4)-12.16%
Max EPS beat(4)17.59%
EPS beat(8)7
Avg EPS beat(8)9%
EPS beat(12)10
Avg EPS beat(12)5.85%
EPS beat(16)13
Avg EPS beat(16)7.06%
Revenue beat(2)0
Avg Revenue beat(2)-1.53%
Min Revenue beat(2)-1.54%
Max Revenue beat(2)-1.52%
Revenue beat(4)0
Avg Revenue beat(4)-1.61%
Min Revenue beat(4)-1.94%
Max Revenue beat(4)-1.43%
Revenue beat(8)0
Avg Revenue beat(8)-1.81%
Revenue beat(12)0
Avg Revenue beat(12)-1.78%
Revenue beat(16)4
Avg Revenue beat(16)-0.6%
PT rev (1m)-1.42%
PT rev (3m)14.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-5.83%
EPS NY rev (3m)26.73%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 78.69
Fwd PE 22.63
P/S 2.88
P/FCF N/A
P/OCF N/A
P/B 5.08
P/tB 9.28
EV/EBITDA N/A
EPS(TTM)0.29
EY1.27%
EPS(NY)1.01
Fwd EY4.42%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.92
BVpS4.49
TBVpS2.46
PEG (NY)0.01
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.79%
ROE -29.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.35%
FCFM N/A
ROA(3y)-15.17%
ROA(5y)-13.29%
ROE(3y)-38%
ROE(5y)-34.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.68%
GM growth 5Y3.13%
F-ScoreN/A
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 1.4
F-ScoreN/A
WACC6.99%
ROIC/WACCN/A
Cap/Depr(3y)93.93%
Cap/Depr(5y)110.89%
Cap/Sales(3y)12.48%
Cap/Sales(5y)15.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)130.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%202.72%
EPS Next Y9274.08%
EPS Next 2Y1103.97%
EPS Next 3Y484.1%
EPS Next 5Y221.17%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%37.8%
Revenue Next Year13.06%
Revenue Next 2Y11.37%
Revenue Next 3Y12.9%
Revenue Next 5Y9.93%
EBIT growth 1Y44.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year137.41%
EBIT Next 3Y44.93%
EBIT Next 5Y28.37%
FCF growth 1Y84.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.82%
OCF growth 3Y-29.26%
OCF growth 5Y-18.41%